Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Windham-Bannister Susan Richards
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HAMILTON JOHN F
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jafri Hasan
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Patzer Eric
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Truong Vu
Aridis Pharmaceuticals | 8-K: Current report
Aridis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Aridis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%), etc.
Aridis Pharmaceuticals | 8-K: Current report
Aridis Pharmaceuticals | DEFA14A: Others
Aridis Pharmaceuticals | 8-K: Current report
Aridis Pharmaceuticals | DEFA14A: Others
Aridis Pharmaceuticals: Q3 2023 Earnings Report
Aridis Pharmaceuticals | 8-K: Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals | DEFA14A: Others
Aridis Pharmaceuticals | ARS: Annual Report to Security Holders
Aridis Pharmaceuticals | DEF 14A: Definitive information statements
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HAMILTON JOHN F
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Windham-Bannister Susan Richards
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Executive Chairman Patzer Eric
No Data